- Home
- GENC vs OBIO Comparison
GENC vs OBIO Comparison
Compare GENC & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENC | OBIO |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.2M | 246.2M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GENC | OBIO |
|---|---|---|
| Price | $15.02 | $4.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $16.00 | $14.25 |
| AVG Volume (30 Days) | 20.0K | ★ 186.3K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.08 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $48,943,000.00 | $2,638,000.00 |
| Revenue This Year | $6.36 | $36.66 |
| Revenue Next Year | $8.32 | $2.30 |
| P/E Ratio | $64.39 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.80 | $2.20 |
| 52 Week High | $17.40 | $5.42 |
Technical Indicators
Market Signals| Indicator | GENC | OBIO |
|---|---|---|
| Relative Strength Index (RSI) | 47.23 | 53.01 |
| Support Level | $14.73 | $4.00 |
| Resistance Level | $15.46 | $5.00 |
| Average True Range (ATR) | 0.52 | 0.27 |
| MACD | -0.17 | 0.03 |
| Stochastic Oscillator | 36.83 | 59.60 |
Price Performance
Historical ComparisonAbout GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.